| 臺大學術典藏 |
2021-01-28T01:06:18Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro K.;Lordick F.;Tsushima T.;Pentheroudakis G.;Baba E.;Lu Z.;Cho B.C.;Nor I.M.;Ng M.;Chen L.-T.;Kato K.;Li J.;Ryu M.-H.;Wan Zamaniah W.I.;Yong W.-P.;Kun-Huei Yeh;Nakajima T.E.;Shitara K.;Kawakami H.;Narita Y.;Yoshino T.;Van Cutsem E.;Martinelli E.;Smyth E.C.;Arnold D.;Minami H.;Tabernero J.;Douillard J.-Y.; Muro K.; Lordick F.; Tsushima T.; Pentheroudakis G.; Baba E.; Lu Z.; Cho B.C.; Nor I.M.; Ng M.; Chen L.-T.; Kato K.; Li J.; Ryu M.-H.; Wan Zamaniah W.I.; Yong W.-P.; KUN-HUEI YEH; Nakajima T.E.; Shitara K.; Kawakami H.; Narita Y.; Yoshino T.; Van Cutsem E.; Martinelli E.; Smyth E.C.; Arnold D.; Minami H.; Tabernero J.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh T.; Kang Y.-K.; Chao Y.; Ryu M.-H.; Kato K.; Cheol Chung H.; Chen J.-S.; Muro K.; Ki Kang W.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Tanimoto M.; Chen L.-T.; Boku N. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen L.-T.;Satoh T.;Ryu M.-H.;Chao Y.;Kato K.;Chung H.C.;Chen J.-S.;Muro K.;Kang W.K.;Kun-Huei Yeh;Yoshikawa T.;Oh S.C.;Bai L.-Y.;Tamura T.;Lee K.-W.;Hamamoto Y.;Kim J.G.;Chin K.;Oh D.-Y.;Minashi K.;Cho J.Y.;Tsuda M.;Sameshima H.;Kang Y.-K.;Boku N.; Chen L.-T.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Kang Y.-K.; Boku N. |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Yang S.-H.;Guo J.-C.;Hsu C.;Kuo S.-H.;Tien Y.-W.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver
|
Ho T.-C.; Wang E.-Y.; KUN-HUEI YEH; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; Chen P.-J.; Yeh S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
|
Yoshino T.; Pentheroudakis G.; Mishima S.; Overman M.J.; KUN-HUEI YEH; Baba E.; Naito Y.; Calvo F.; Saxena A.; Chen L.-T.; Takeda M.; Cervantes A.; Taniguchi H.; Yoshida K.; Kodera Y.; Kitagawa Y.; Tabernero J.; Burris H.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.;Tai J.J.;Chen L.-T.;Wu M.-S.;Kun-Huei Yeh;Lin C.-W.;Wang T.-E.;Wang H.-P.;Yu F.-J.;Liou J.-M.;Hsiao C.-F.;Cheng T.-Y.;Yeh H.-J.;Ko C.-W.;Chen M.-J.;Lo G.-H.;Hsu P.-I.;Chang C.-S.;Hwang W.-S.;Chuang S.-S.;Lee H.-W.;Shun C.-T.;Chiu C.-F.;Wang W.-M.;Hsieh C.-Y.;Liu T.-W.;Lin J.-T.;Kuo S.-H.;Cheng A.-L.; Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; KUN-HUEI YEH; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Rau K.-M.;Rau K.-M.;Shun S.-C.;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Kun-Huei Yeh;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Rau K.-M.; Rau K.-M.; Shun S.-C.; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.;Kun-Huei Yeh;Yao M.;Tang J.-L.;Lin C.-W.;Wang Y.-T.;Yeh Y.-C.;Wang H.-P.;Cheng A.-L.;Kuo S.-H.; Ma W.-L.; KUN-HUEI YEH; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Kun-Huei Yeh;Yang T.-S.;Hsu T.-C.;Tzu-Liang Chen W.;Chen H.-H.;Teng H.-W.;Lin B.-W.;Kuan F.-C.;Chiang F.-F.;Duann C.-W.;Li Y.-S.;Lin M.-T.;Fiala-Buskies S.;Ducreux M.;Wang J.-Y.; KUN-HUEI YEH; Yang T.-S.; Hsu T.-C.; Tzu-Liang Chen W.; Chen H.-H.; Teng H.-W.; Lin B.-W.; Kuan F.-C.; Chiang F.-F.; Duann C.-W.; Li Y.-S.; Lin M.-T.; Fiala-Buskies S.; Ducreux M.; Wang J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:13Z |
A Pilot Study of Metabolomic Pathways Associated With Fatigue in Survivors of Colorectal Cancer
|
Chou Y.-J.;Kober K.M.;Kuo C.-H.;Kun-Huei Yeh;Kuo T.-C.;Tseng Y.J.;Miaskowski C.;Liang J.-T.;Shun S.-C.; Chou Y.-J.; Kober K.M.; Kuo C.-H.; KUN-HUEI YEH; Kuo T.-C.; Tseng Y.J.; Miaskowski C.; Liang J.-T.; Shun S.-C. |
| 臺大學術典藏 |
2021-01-18T09:12:10Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
KUN-HUEI YEH; Yang, Tsai Sheng; Hsu, Tzu Chi; Tzu-Liang Chen, William; Chen, Hong Hwa; Teng, Hao Wei; Lin, Bo Wen; Kuan, Feng Che; Chiang, Feng Fan; Duann, Chi Wei; Li, Ying Shiuan; Lin, Meng Ting; Fiala-Buskies, Sabine; Ducreux, Michel; Wang, Jaw Yuan |
| 臺大學術典藏 |
2020-02-20T06:52:59Z |
Recent Advances in Systemic Therapy for Advanced Pancreatic Cancer
|
SHIH-HUNG YANG; WEI-CHIH LIAO; YU-WEN TIEN; KUN-HUEI YEH |
| 臺大學術典藏 |
2019-08-05T08:19:51Z |
Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
|
ANN-LII CHENG;Chen, Li-Tzong;PING-NING HSU;CHUNG-WU LIN;KUN-HUEI YEH;MING-SHIANG WU;SUNG-HSIN KUO; SUNG-HSIN KUO; MING-SHIANG WU; KUN-HUEI YEH; CHUNG-WU LIN; PING-NING HSU; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:56:05Z |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
ANN-LII CHENG;Chen, Li-Tzong;PING-NING HSU;MING-SHIANG WU;CHIA-TUNG SHUN;Wei, Ming-Feng;Lee, Hsiao-Wei;KUN-HUEI YEH;CHUNG-WU LIN;Tsai, Hui-Jen;SUNG-HSIN KUO; SUNG-HSIN KUO; Tsai, Hui-Jen; CHUNG-WU LIN; KUN-HUEI YEH; Lee, Hsiao-Wei; Wei, Ming-Feng; CHIA-TUNG SHUN; MING-SHIANG WU; PING-NING HSU; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:55:01Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
ANN-LII CHENG;PING-NING HSU;MING-SHIANG WU;JYH-MING LIOU;Tzeng, Yi-Shin;CHIA-TUNG SHUN;KUN-HUEI YEH;CHUNG-WU LIN;Chen, Li-Tzong;SUNG-HSIN KUO; SUNG-HSIN KUO; Chen, Li-Tzong; CHUNG-WU LIN; KUN-HUEI YEH; CHIA-TUNG SHUN; Tzeng, Yi-Shin; JYH-MING LIOU; MING-SHIANG WU; PING-NING HSU; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:38:07Z |
Helicobacter pylori CagA Translocation Is Closely Associated With the Expression of CagA-signaling Molecules in Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma
|
ANN-LII CHENG;Tzeng, Yi-Shin;Tsai, Hui-Jen;JYH-MING LIOU;MING-SHIANG WU;PING-NING HSU;CHUNG-WU LIN;Chen, Li-Tzong;KUN-HUEI YEH;SUNG-HSIN KUO; SUNG-HSIN KUO; KUN-HUEI YEH; Chen, Li-Tzong; CHUNG-WU LIN; PING-NING HSU; MING-SHIANG WU; JYH-MING LIOU; Tsai, Hui-Jen; Tzeng, Yi-Shin; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:12:47Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
ANN-LII CHENG;Chen, Li-Tzong;HSIU-PO WANG;PING-NING HSU;CHUNG-WU LIN;MING-SHIANG WU;KUN-HUEI YEH;SUNG-HSIN KUO; SUNG-HSIN KUO; KUN-HUEI YEH; MING-SHIANG WU; CHUNG-WU LIN; PING-NING HSU; HSIU-PO WANG; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:10:39Z |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma
|
KUN-HUEI YEH; Tsai, Hui-Jen; Chen, Li-Tzong; ANN-LII CHENG; ANN-LII CHENG;Chen, Li-Tzong;Tsai, Hui-Jen;KUN-HUEI YEH;Jeng, Huei-Jiuan;CHUNG-WU LIN;MING-SHIANG WU;PING-NING HSU;Chen, Zi-Hua;Weng, Wen-Hui;SUNG-HSIN KUO; SUNG-HSIN KUO; Weng, Wen-Hui; Chen, Zi-Hua; PING-NING HSU; MING-SHIANG WU; CHUNG-WU LIN; Jeng, Huei-Jiuan |
| 臺大學術典藏 |
2019-08-05T06:59:55Z |
Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma
|
ANN-LII CHENG; ANN-LII CHENG;Lin, Jaw-Town;PING-NING HSU;Chen, Jing-Yi;Tzeng, Yi-Shin;KUN-HUEI YEH;CHUNG-WU LIN;MING-SHIANG WU;Chen, Li-Tzong;Yeh, Pei-Yen;SUNG-HSIN KUO; SUNG-HSIN KUO; Yeh, Pei-Yen; Chen, Li-Tzong; MING-SHIANG WU; CHUNG-WU LIN; KUN-HUEI YEH; Tzeng, Yi-Shin; Chen, Jing-Yi; PING-NING HSU; Lin, Jaw-Town |
| 臺大學術典藏 |
2019-08-05T06:38:53Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment
|
Tzeng, Yi-Shin; HSIU-PO WANG; PING-NING HSU; Lin, Jaw-Town; ANN-LII CHENG; ANN-LII CHENG;Lin, Jaw-Town;PING-NING HSU;HSIU-PO WANG;Tzeng, Yi-Shin;Yeh, Pei-Yen;KUAN-TING KUO;KUN-HUEI YEH;CHUNG-WU LIN;MING-SHIANG WU;Chen, Li-Tzong;SUNG-HSIN KUO; SUNG-HSIN KUO; Chen, Li-Tzong; MING-SHIANG WU; CHUNG-WU LIN; KUN-HUEI YEH; KUAN-TING KUO; Yeh, Pei-Yen |
| 臺大學術典藏 |
2019-04-24T02:25:03Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen, Kuo-Hsing;Yu-Lin Lin;Jau-Yu Liau;Tsai, Jia-Huei;Li-Hui Tseng;Liang-In Lin;Jin-Tung Liang;Been-Ren Lin;Ji-Shiang Hung;Yih-Leong Chang;Kun-Huei Yeh;Ann-Lii Cheng; Chen, Kuo-Hsing; YU-LIN LIN; JAU-YU LIAU; Tsai, Jia-Huei; LI-HUI TSENG; LIANG-IN LIN; JIN-TUNG LIANG; BEEN-REN LIN; JI-SHIANG HUNG; YIH-LEONG CHANG; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:22:36Z |
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma
|
Li, C.-L. and Yeh, K.-H. and Liu, W.-H. and Chen, C.-L. and Chen, D.-S. and Chen, P.-J. and Yeh, S.-H.; Li, Chiao-Ling;Yeh, Kun-Huei;Liu, Wan-Hsin;Chen, Chi-Ling;Chen, Ding-Shinn;Chen, Pei-Jer;Yeh, Shiou-Hwei; 陳定信;葉坤輝;葉秀慧;陳培哲;陳祈玲; Li, Chiao-Ling; Li, Chiao-Ling; PEI-JER CHEN; Yeh, Kun-Huei; Yeh, Kun-Huei; KUN-HUEI YEH; Liu, Wan-Hsin; DING-SHINN CHEN; Liu, Wan-Hsin; SHIOU-HWEI YEH; Chen, Chi-Ling; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Pei-Jer; Chen, Pei-Jer; Yeh, Shiou-Hwei; Yeh, Shiou-Hwei; 陳祈玲 |
